Center for Biopharmaceuticals, Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Clin Res Cardiol. 2018 Aug;107(8):670-678. doi: 10.1007/s00392-018-1233-3. Epub 2018 Mar 26.
Unexplained cardiac arrest (UCA) is often the first manifestation of an inherited arrhythmogenic disease. Genetic testing in UCA is challenging due to the complexities of variant interpretation in the absence of supporting cardiac phenotype. We aimed to investigate if a KCNQ1 variant [p.(Pro64_Pro70del)], previously reported as pathogenic, contributes to the long-QT syndrome phenotype, co-segregates with disease or affects KCNQ1 function in vitro.
DNA was extracted from peripheral blood of a 22-year-old male after resuscitation from UCA. Targeted exome sequencing was performed using the TruSight-One Sequencing Panel (Illumina). Variants in 190 clinically relevant cardiac genes with minor allele frequency < 1% were analyzed according to the guidelines of the American College of Medical Genetics. Functional characterization was performed using site-directed mutagenesis, expression in Xenopus laevis oocytes using the two-electrode voltage-clamp technique.
The 12-lead ECG, transthoracic echocardiography and coronary angiography after resuscitation showed no specific abnormalities. Two variants were identified: c.190_210del in-frame deletion in KCNQ1 (p.Pro64_Pro70del), reported previously as pathogenic and c.2431C > A in PKP2 (p.Arg811Ser), classified as likely benign. Two asymptomatic family members with no evident phenotype hosted the KCNQ1 variant. Functional studies showed that the wild-type and mutant channels have no significant differences in current levels, conductance-voltage relationships, as well as activation and deactivation kinetics, in the absence and presence of the auxiliary subunit KCNE1.
Based on our data and previous reports, available evidence is insufficient to consider the variant KCNQ1:c.190_210del as pathogenic. Our findings call for cautious interpretation of genetic tests in UCA in the absence of a clinical phenotype.
不明原因心搏骤停(UCA)通常是遗传性心律失常疾病的首发表现。由于在缺乏心脏表型支持的情况下,变异解读较为复杂,UCA 中的基因检测具有挑战性。我们旨在研究先前报道为致病性的 KCNQ1 变异 [p.(Pro64_Pro70del)] 是否导致长 QT 综合征表型、与疾病共分离或影响体外 KCNQ1 功能。
从 UCA 复苏后的 22 岁男性外周血中提取 DNA。使用 TruSight-One 测序面板(Illumina)进行靶向外显子组测序。根据美国医学遗传学学院的指南,分析了 190 种临床相关心脏基因中的变异,这些基因的等位基因频率 < 1%。使用定点诱变、双电极电压钳技术在非洲爪蟾卵母细胞中表达进行功能特征分析。
复苏后的 12 导联心电图、经胸超声心动图和冠状动脉造影均未见特异性异常。鉴定出两种变异:KCNQ1 中的 c.190_210del 框内缺失(p.Pro64_Pro70del),先前报道为致病性,PKP2 中的 c.2431C > A(p.Arg811Ser),分类为可能良性。两名无症状的家族成员携带该 KCNQ1 变异但无明显表型。功能研究表明,在不存在辅助亚基 KCNE1 的情况下,野生型和突变型通道在电流水平、电导-电压关系以及激活和失活动力学方面没有显著差异。
根据我们的数据和以往的报告,现有证据不足以将变异 KCNQ1:c.190_210del 视为致病性。我们的发现呼吁在缺乏临床表型的情况下,对 UCA 中的基因检测进行谨慎解读。